Mary Clark

Featured in: Favicon

nature.com Favicon

science.org Favicon

shawlocal.com Favicon

jaadcasereports.org

Articles

Donor-derived CD19-targeted chimeric antigen receptor T cells in adult transplant recipients with relapsed/refractory acute lymphoblastic leukemia - Blood Cancer Journal

Jul 12, 2023 | nature.com | Ibrahim Aldoss |Yan Wang |Xiuli Wang |Mary Clark

Dear Editor,CD19-targeted chimeric antigen receptor (CAR) T cell therapy induces remission in the majority of patients with relapsed and refractory (r/r) B-cell acute lymphoblastic leukemia (ALL), including those who have exhausted all other available salvage therapies [1,2,3].

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →